Discontinued Operations (Tables)

3 Months Ended

Dec. 31, 2012

Operating Results from Discontinued Operations

The following is a summary of the operating results of SurModics Pharmaceuticals from discontinued operations for the three months ended December 31, 2011 (in thousands):

	Three Months Ended
	December 31,
	2011
Total revenue	$	5,311
Income from discontinued operations	$	2,530
Income tax provision		(925	)
Income from discontinued operations, net of income taxes	$	1,605
Loss on sale of discontinued operations	$	(1,661	)
Income tax benefit		607
Loss on sale of discontinued operations, net of income taxes	$	(1,054	)

Assets and Liabilities of Discontinued Operations

The major classes of assets and liabilities of discontinued operations as of December 31, 2012 and September 30, 2012 were as follows (in thousands):

	December 31,		September 30,
	2012		2012
Accounts receivable, net	$	209	$	283
Other current assets		600		600
Current assets of discontinued operations		809		883
Total assets of discontinued operations	$	809	$	883
Other current liabilities payable	$	1,640	$	1,640
Current liabilities of discontinued operations		1,640		1,640
Total liabilities of discontinued operations	$	1,640	$	1,640